Clinical trial Recruiting at 9 sites Interventional Ages 18 and up

Treatment of nighttime high blood pressure

Official title: A Prospective, Randomized, Open-label Clinical Trial on the Effects of Intensive Versus Conventional Control of Ambulatory-determined Asleep Systolic Blood Pressure Mean on Cardiovascular, Metabolic, and Renal Disease Risks

Run by University of Vigo · NCT03457168 · Data updated 2026-11-12

This study tests a new way to treat high blood pressure that happens at night to see if it can help improve heart health.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment5320 (estimated)
SponsorUniversity of Vigo
Academic / other
Locations9 sites (Ourense, Orense and 8 other locations)
StatusRecruiting
StartedFebruary 1, 2019
Main results expectedDecember 31, 2031
Study endsDecember 31, 2032
Registry record updatedDecember 6, 2024
Trial IDNCT03457168 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are men and women aged 18 and older who experience sleep-time hypertension with a mean asleep systolic blood pressure of 120 mmHg or higher.

Probably not a fit

Patients with certain cardiovascular disorders or secondary forms of hypertension may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the treatment of hypertension that occurs during sleep, focusing on the relationship between blood pressure measurements taken at night and cardiovascular health. It utilizes ambulatory blood pressure monitoring to assess patients' sleep-time blood pressure levels, aiming to establish effective treatment protocols based on these measurements. The study is grounded in recent guidelines that emphasize the importance of nighttime blood pressure control in reducing cardiovascular risks.

Why it matters

Potential benefit: If successful, this approach could lead to improved management of hypertension during sleep, potentially reducing cardiovascular disease risk for patients.

How similar studies have gone: Other studies have indicated the importance of nighttime blood pressure management, suggesting that this approach may yield beneficial results.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Men and women aged ≥18 years.
2. All participants must: (i) have at randomization sleep-time hypertension according to the current ESH/ESC guidelines, i.e., asleep SBP mean ≥120 mmHg;1 (ii) adhere to a routine of daytime activity and nighttime sleep; and (iii) provide their written informed consent to participate into the study.

Exclusion Criteria:

1. Pregnancy.
2. History of drug/alcohol abuse within the last two years.
3. Night/shift-work employment.
4. Previous history of a systemic autoimmune disease or AIDS.
5. Evidence of a secondary form of hypertension, including coarctation of the aorta, hyperaldosteronism, renal artery stenosis, or pheochromocytoma
6. CVD disorders (unstable angina pectoris, heart failure, life-threatening arrhythmia, atrial fibrillation, kidney failure, and grade III-IV retinopathy). Previous CVD events will not be exclusionary if full physical and work activities are maintained.
7. Any surgical or medical condition which might alter the absorption, distribution, metabolism, or excretion of any drug, or, at the discretion of the investigator, might place the subject at higher risk from his/her participation in the study, or are likely to prevent the subject from complying with the requirements of the study or completing the trial period.
8. History of malignancy including leukemia and lymphoma (but not basal cell skin cancer), or any other severe, life-threatening disease within the past five years.
9. Inability to communicate and comply with all study requirements.
10. Intolerance to ABPM.

Where it's running

  • Complexo Hospitalario Universitario de Ourense
    Ourense, Orense, Spain
    Recruiting
  • CS A Estrada
    A Estrada, Pontevedra, Spain
    Recruiting
  • CS Panxón
    Nigrán, Pontevedra, Spain
    Recruiting
  • Centro de Salud de A Doblada
    Vigo, Pontevedra, Spain
    Recruiting
  • Centro de Salud de Bembrive
    Vigo, Pontevedra, Spain
    Recruiting
  • Centro de Salud de Sardoma
    Vigo, Pontevedra, Spain
    Recruiting
Show 3 more locations
  • CS Teis
    Vigo, Pontevedra, Spain
    Recruiting
  • Bioengineering & Chronobilogy Labs., University of Vigo
    Vigo, Pontevedra, Spain
    Recruiting
  • CS San Roque
    Vilagarcía de Arousa, Pontevedra, Spain
    Recruiting

Study contacts

  • Principal investigator: Ramon C Hermida, PhD — University of Vigo
  • Study coordinator: Ramon C Hermida, PhD
  • Email: rhermida@uvigo.es
  • Phone: 34986812148

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.